转移因子(TF)是人体白细胞的提出物,现已证实,它可对既往无反应性的人体受者转递特异性皮肤试验的反应性,并且在体外淋巴细胞活性试验中产生可测定的增长。文中复习了转移因子作为免疫疗法的制剂在实验性应用中的结果。实验证实,转移因子可使肿瘤退化和暂时稳定,某些癌症病例据报道可减少使用其它治疗手段,并且对某些恶性病可能是有价值的辅助治疗。然而这些报道大多数缺乏对照研究,而且关 The transfer factor (TF) is a human leukocyte presenter, which has been confirmed to transmit the reactivity of a specific skin test to previously unresponsive human subjects and to produce measurable growth in in vitro lymphocyte activity assays. . The article reviews the results of experimental applications of transfer factors as immunotherapeutic agents. Experiments have confirmed that metastatic factors can degenerate and temporarily stabilize tumors. Some cancer cases are reported to reduce the use of other treatments and may be valuable adjuvant treatments for certain malignancies. However, most of these reports lack control studies and